Skip to content
Lower risk Medical device recall · FDA · Published March 7, 2023

Compass Health REX Pressure Therapy System Recall: Manual Error May Mislead DVT Use

Compass Health recalls REX Pressure Therapy System user manuals due to an error indicating DVT prevention without proper FDA approval. This may lead to unsafe use of the device for deep vein thrombosis prevention.

🇺🇸 FDA recall #Z-1398-2023Medical deviceCompass Health ›
Take action

Contact the company

Recalling firmCompass Health Brands (Corporate Office)6753 Engle Rd · Middleburg Heights, OH 44130-7934
✎ GovInfoNow plain-language explainer

Compass Health is recalling the REX Pressure Therapy System user manuals because they contain an error suggesting the device can prevent deep vein thrombosis (DVT) without the necessary FDA approval. This could lead to unsafe use of the device for DVT prevention. Read more at govinfonow.com/recall/58784-compass-health-rex-pressure-therapy-system-recall-manual-error-may.

Source Summary by GovInfoNow · govinfonow.com/recall/58784-compass-health-rex-pressure-therapy-system-recall-manual-error-may · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1398-2023

Cite this page

“Compass Health REX Pressure Therapy System Recall: Manual Error May Mislead DVT Use.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/58784-compass-health-rex-pressure-therapy-system-recall-manual-error-may. Based on FDA recall #Z-1398-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1398-2023%22&limit=1).

The FDA announced on March 7, 2023, that Compass Health Brands is recalling the REX (Recovery Exercise X-Trainer) Pressure Therapy System user manual. The recall addresses an error indicating the device may prevent deep vein thrombosis, a use for which it was marketed without clearance.

How to tell if you have it

  • Brand: Compass Health
  • Product: REX (Recovery Exercise X-Trainer) Pressure Therapy System- USER Manual
  • Models: DVTREX-U and DVTREX -L
  • UDI-DI (DVTREX-L): 00092237622933
  • UDI-DI (DVTREX-U): 00092237622926
  • Quantity: 30 units

The hazard

The user manual contains an error in the Introduction section that indicates the device may be used for the prevention of deep vein thrombosis (DVT). The device was marketed without a 510(k) clearance for this specific indication.

Context

GovInfoNow's records show Compass Health Brands has issued three other recalls since June 18, 2018, including a Voyager Rollator recall on Jan. 10, 2022, and a MediPress Full Leg Compression System recall on April 8, 2019. Other recent recalls of similar products include the Boston Scientific ENROUTE Transcarotid Neuroprotection System recall (July 9, 2026), the Bard Safe-T-Centesis 6 Fr Catheter Drainage Tray recall (Nov. 6, 2025), and the INSPIREMD CGuard Prime Carotid Stent System recall (May 1, 2026).

How to tell if you have this one

Check for the DVTREX-U or DVTREX-L models with serial numbers starting with 00092237622926 or 00092237622933. All units produced are affected.

  • Brand
    Compass Health
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Review User Manual

    Check if the manual contains the error about DVT prevention without FDA approval.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide and the country of Canada.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 50 days after the firm started it.

1. Firm started the recall: Mar 7, 202312. FDA classified it Class II: Apr 18, 202323. Published in FDA’s Enforcement Report: Apr 26, 202332023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1398-2023 (March 7, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1398-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA